Advanced in Gout

Dr. Asif Cochinwala

Rheumatology
1631 N Loop W, Suite 480, 
Houston, TX 
 (1249.3 mi)
Accepting New Patients
Advanced in Gout
1631 N Loop W, Suite 480, 
Houston, TX 
 (1249.3 mi)
OverviewInsuranceLocationsClinical Research

Overview

Asif Cochinwala is a Rheumatologist in Houston, Texas. Dr. Cochinwala and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are Rheumatoid Arthritis (RA), Sjogren Syndrome, Undifferentiated Connective Tissue Disease (UCTD), and Interstitial Keratitis. Dr. Cochinwala is currently accepting new patients.

His clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Internal Medicine in TX
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Community Health
  •  Humana

Locations

1631 N Loop W, Suite 480, Houston, TX 77008
Other Locations
21212 Northwest Fwy, Suite 375, Cypress, TX 77429
9614 Huffmeister Rd, Houston, TX 77095

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study Comparing GSK3196165 With Placebo and With Tofacitinib, in Combination With Methotrexate in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Biological, Drug
Study Drugs: GSK3196165, Tofacitinib, Methotrexate, Folic acid
Study Phase: Phase 3
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
A 24-week, Phase 3, Multicentre, Randomised, Double-blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Sarilumab, in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Biological DMARDs and/or Janus Kinase Inhibitors
Enrollment Status: Completed
Publish Date: July 17, 2023
Intervention Type: Drug, Biological
Study Drugs: GSK3196165, Sarilumab, csDMARDs
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Distinguished in Gout
Dr. Prashanth R. Sunkureddi
Rheumatology
Distinguished in Gout
Dr. Prashanth R. Sunkureddi
Rheumatology

Prashanth R. Sunkureddi, M.D., P.A.

3725 E League City Pkwy, Suite 200, 
League City, TX 
 (31.7 mi)
281-957-9127
Languages Spoken:
English
See accepted insurances

Prashanth Sunkureddi is a Rheumatologist in League City, Texas. Dr. Sunkureddi and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are Arthritis, Gout, Rheumatoid Arthritis (RA), and Psoriatic Arthritis.

Advanced in Gout
Dr. Vijaya L. Murthy
Rheumatology
Advanced in Gout
Dr. Vijaya L. Murthy
Rheumatology

Utmb Faculty Group Practice

301 University Blvd, 
Galveston, TX 
 (52.3 mi)
409-772-2222
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Vijaya Murthy is a Rheumatologist in Galveston, Texas. Dr. Murthy and is rated as an Advanced provider by MediFind in the treatment of Gout. Her top areas of expertise are Rheumatoid Arthritis (RA), Rhizomelic Pseudopolyarthritis, Gout, and Lupus Nephritis. Dr. Murthy is currently accepting new patients.

Advanced in Gout
Dr. Emilio B. Gonzalez
Rheumatology
Advanced in Gout
Dr. Emilio B. Gonzalez
Rheumatology
301 University Blvd, 
Galveston, TX 
 (52.3 mi)
409-772-2222
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients

Emilio Gonzalez is a Rheumatologist in Galveston, Texas. Dr. Gonzalez and is rated as an Advanced provider by MediFind in the treatment of Gout. His top areas of expertise are MASS Phenotype, Mixed Connective Tissue Disease, Rheumatoid Arthritis (RA), and Adult Still's Disease. Dr. Gonzalez is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile